Continuous Glucose Monitoring Devices Market by Product and End User - Global Industry Analysis and Forecast to 2027
Published On : May 2022 Pages : 101 Category: Medical Devices Report Code : HC0621
Industry Trend Analysis
The continuous glucose monitoring (CGM) devices market is expected to be around $1.1 billion by 2027. Rising incidence of diabetes worldwide, technological advancements in CGM devices (such as advent of artificial pancreas), and rising awareness about the availability of CGM devices are the factors responsible for the growth of this market. However, stringent regulations and expensive CGM devices are set to hamper the market growth.
Product Outlook and Trend Analysis
Transmitter and receivers segment accounted for the largest share of the overall market in 2017, whereas the insulin pumps market is projected to be the fastest-growing segment during the forecast period due to precise insulin delivery, decreasing episodes of severe hypoglycemia and high blood glucose control.
End User Outlook and Trend Analysis
Homecare diagnostics segment held the major share of the global market in 2017, due to efficiency and user-friendly nature of the CGM devices. Patients can use these devices without the technical support from hospital staff. Thus, the insulin can be administered by the patient itself.
Regional Outlook and Trend Analysis
North America accounted for the largest share of the overall market in 2017. This is attributed to increase in the number of obese patients, sedentary lifestyle and high adoption of advanced CGM devices. Asia-Pacific is expected to be the fastest growing region during the forecasted period, due to high patient population with rapidly aging population and increasing patient awareness about the availability of CGM devices with growing disposable income of people.
Competitive Analysis
Abbott Laboratories, Nemaura Medical Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Johnson and Johnson, Dexcom, Inc., F. Hoffmann-La Roche AG, Medtronic, Echo Therapeutics, Inc, Senseonics Holdings, Inc., and GlySens Incorporated are the major players operating in the continuous glucose monitoring devices market.
Market Opportunities
CGMS technology has opened up a new way for the most awaited, high-tech, closed-loop 'artificial/bionic pancreas'. The artificial pancreas can significantly improve diabetes care and management. It can reduce the burden of monitoring and managing blood glucose. Thus, development of artificial pancreas will bring in new growth avenues for the key players in the market.
Continuous Glucose Monitoring Devices Market Segmentation
By Product:
- Insulin Pumps
- Transmitters and Receivers
- Sensors
By End User:
- Homecare Diagnostics
- Hospitals
- Others
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- Turkey
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Continuous Glucose Monitoring Devices Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
- Transmitters and Receivers
- Sensors
- Insulin Pumps
- Continuous Glucose Monitoring Devices Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
- Hospitals
- Homecare Diagnostics
- Others
- Continuous Glucose Monitoring Devices Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Continuous Glucose Monitoring Devices Market, By Country
- North America Continuous Glucose Monitoring Devices Market, By Product
- North America Continuous Glucose Monitoring Devices Market, By End User
- U.S. Continuous Glucose Monitoring Devices Market, By Product
- U.S. Continuous Glucose Monitoring Devices Market, By End User
- Canada Continuous Glucose Monitoring Devices Market, By Product
- Canada Continuous Glucose Monitoring Devices Market, By End User
- Mexico Continuous Glucose Monitoring Devices Market, By Product
- Mexico Continuous Glucose Monitoring Devices Market, By End User
-
- Europe
- Europe Continuous Glucose Monitoring Devices Market, By Country
- Europe Continuous Glucose Monitoring Devices Market, By Product
- Europe Continuous Glucose Monitoring Devices Market, By End User
- Germany Continuous Glucose Monitoring Devices Market, By Product
- Germany Continuous Glucose Monitoring Devices Market, By End User
- France Continuous Glucose Monitoring Devices Market, By Product
- France Continuous Glucose Monitoring Devices Market, By End User
- UK Continuous Glucose Monitoring Devices Market, By Product
- UK Continuous Glucose Monitoring Devices Market, By End User
- Italy Continuous Glucose Monitoring Devices Market, By Product
- Italy Continuous Glucose Monitoring Devices Market, By End User
- Spain Continuous Glucose Monitoring Devices Market, By Product
- Spain Continuous Glucose Monitoring Devices Market, By End User
- Rest of Europe Continuous Glucose Monitoring Devices Market, By Product
- Rest of Europe Continuous Glucose Monitoring Devices Market, By End User
-
- Asia-Pacific
- Asia-Pacific Continuous Glucose Monitoring Devices Market, By Country
- Asia-Pacific Continuous Glucose Monitoring Devices Market, By Product
- Asia-Pacific Continuous Glucose Monitoring Devices Market, By End User
- Japan Continuous Glucose Monitoring Devices Market, By Product
- Japan Continuous Glucose Monitoring Devices Market, By End User
- China Continuous Glucose Monitoring Devices Market, By Product
- China Continuous Glucose Monitoring Devices Market, By End User
- Australia Continuous Glucose Monitoring Devices Market, By Product
- Australia Continuous Glucose Monitoring Devices Market, By End User
- India Continuous Glucose Monitoring Devices Market, By Product
- India Continuous Glucose Monitoring Devices Market, By End User
- South Korea Continuous Glucose Monitoring Devices Market, By Product
- South Korea Continuous Glucose Monitoring Devices Market, By End User
- Rest of Asia-Pacific Continuous Glucose Monitoring Devices Market, By Product
- Rest of Asia-Pacific Continuous Glucose Monitoring Devices Market, By End User
- Asia-Pacific
-
- Rest of the World
- Rest of the World Continuous Glucose Monitoring Devices Market, By Country
- Rest of the World Continuous Glucose Monitoring Devices Market, By Product
- Rest of the World Continuous Glucose Monitoring Devices Market, By End User
- Brazil Continuous Glucose Monitoring Devices Market, By Product
- Brazil Continuous Glucose Monitoring Devices Market, End User
- South Africa Continuous Glucose Monitoring Devices Market, By Product
- South Africa Continuous Glucose Monitoring Devices Market, By End User
- Saudi Arabia Continuous Glucose Monitoring Devices Market, By Product
- Saudi Arabia Continuous Glucose Monitoring Devices Market, By End User
- Turkey Continuous Glucose Monitoring Devices Market, By Product
- Turkey Continuous Glucose Monitoring Devices Market, By End User
- United Arab Emirates Continuous Glucose Monitoring Devices Market, By Product
- United Arab Emirates Continuous Glucose Monitoring Devices Market, By End User
- Others Continuous Glucose Monitoring Devices Market, By Product
- Others Continuous Glucose Monitoring Devices Market, By End User
- Rest of the World
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Increasing Prevalence of Diabetes
3.3.1.2. Technological Advancements
3.3.1.3. Rising Awareness about the Availability of CGM Devices
3.3.2. Restraints
3.3.2.1. High Cost of Continuous Glucose Monitoring Devices
3.3.2.2. Strict Regulatory Norms and Insufficient Reimbursement Options
3.3.3. Opportunities
3.3.3.1. Development of Artificial Pancreas
3.3.3.2. Emerging Markets
3.4. Industry Trends
3.5. Reimbursement Scenario
4. Continuous Glucose Monitoring Devices Market , By Product
4.1. Introduction
4.2. Continuous Glucose Monitoring Devices Market Assessment and Forecast, By Product, 2017-2027
4.3. Transmitter & Receivers
4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4. Sensors
4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.5. Insulin Pumps
4.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5. Continuous Glucose Monitoring Devices Market , By End User
5.1. Continuous Glucose Monitoring Devices Market Assessment and Forecast, By End User, 2017-2027
5.2. Hospitals
5.2.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.3. Homecare Diagnostics
5.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4. Others
5.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6. Continuous Glucose Monitoring Devices Market , By Region
6.1. Introduction
6.2. Continuous Glucose Monitoring Devices Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.3. North America
6.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.3.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.1. U.S.
6.3.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.2. Canada
6.3.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.3. Mexico
6.3.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4. Europe
6.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.4.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.1. Germany
6.4.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.2. France
6.4.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.3. UK
6.4.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.4. Italy
6.4.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.5. Spain
6.4.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.6. Russia
6.4.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.3.7. Rest of Europe
6.4.3.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.7.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5. Asia-Pacific
6.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.5.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.1. Japan
6.5.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.2. China
6.5.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.3. Australia
6.5.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.4. India
6.5.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.5. South Korea
6.5.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.6. Taiwan
6.5.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.7. Rest of Asia-Pacific
6.5.3.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.7.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6. Rest of the World
6.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.6.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.1. Brazil
6.6.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.2. Turkey
6.6.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.2.3.
6.6.3.3. Saudi Arabia
6.6.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.3.3.
6.6.3.4. South Africa
6.6.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.4.3.
6.6.3.5. United Arab Emirates
6.6.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.5.3.
6.6.3.6. Others
6.6.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7. Company Profiles
7.1. Medtronic
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Key Financials
7.1.4. Strategic Developments
7.2. Dexcom
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Key Financials
7.2.4. Strategic Developments
7.3. Abbott
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Key Financials
7.3.4. Strategic Developments
7.4. Johnson and Johnson
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Key Financials
7.4.4. Strategic Developments
7.5. Insulet corp.
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Key Financials
7.5.4. Strategic Developments
7.6. Tandem diabetes
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Key Financials
7.6.4. Strategic Developments
7.7. Echo therapeutics
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Key Financials
7.7.4. Strategic Developments
7.8. Roche diagnostics
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Key Financials
7.8.4. Strategic Developments
7.9. Nemaura medical Inc.
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Key Financials
7.9.4. Strategic Developments
7.10. Senseonics
7.10.1. Business Overview
7.10.2. Product Portfolio
7.10.3. Key Financials
7.10.4. Strategic Developments
List of Tables
Table 1.Global Continuous Glucose Monitoring Devices Market, By Product ($Million), 2017-2025
Table 2.Transmitters & Receivers Market, By Region ($Million), 2017-2025
Table 3.Sensors Market, By Region ($Million), 2017-2025
Table 4.Insulin Pumps Market, By Region ($Million), 2017-2025
Table 5.Global Continuous Glucose Monitoring Devices Market, By End User ($Million), 2017-2025
Table 6.Hospitals Market, By Region ($Million), 2017-2025
Table7.Homecare Diagnostics Market, By Region ($Million), 2017-2025
Table 8.Continuous Glucose Monitoring Devices Market, By Region, 2017-2025 ($Million)
Table 9.North America Continuous Glucose Monitoring Devices Market, By Country, 2017-2025 ($Million)
Table 10.North America Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 11.North America Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 12.U.S. Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 13.U.S. Continuous Glucose Monitoring Devices Market,By End User, 2017-2025 ($Million)
Table 14.Canada Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 15.Canada Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 16.Mexico Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 17.Mexico Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 18.Europe Continuous Glucose Monitoring Devices Market, By Country, 2017-2025 ($Million)
Table 19.Europe Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 20.Europe Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 21.Germany Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 22.Germany Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 23.France Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 24.France Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 25.UK Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 26.UK Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 27.Italy Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 28.Italy Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 29.Spain Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 30.Spain Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 31.Russia Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 32.Russia Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 33.Rest of Europe Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 34.Rest of Europe Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 35.Asia-Pacific Continuous Glucose Monitoring Devices Market, By Country, 2017-2025 ($Million)
Table 36.Asia-Pacific Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 37.Asia-Pacific Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 38.Japan Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 39.Japan Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 40.China Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 41.China Continuous Glucose Monitoring Devices Market,By End User, 2017-2025 ($Million)
Table 42.Australia Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 43.Australia Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 44.India Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 45.India Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 46.South Korea Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 47.South Korea Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 48.Taiwan Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 49.Taiwan Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 50.Rest of Asia-Pacific Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 51.Rest of Asia-Pacific Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 52.Rest of the World Continuous Glucose Monitoring Devices Market, By Country, 2017-2025 ($Million)
Table 53.Rest of the World Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 54.Rest of the World Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 55.Brazil Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 56.Brazil Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 57.Turkey Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 58.Turkey Continuous Glucose Monitoring Devices Market,By End User, 2017-2025 ($Million)
Table 59.Saudi Arabia Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 60.Saudi Arabia Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 61.South Africa Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 62.South Africa Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 63.United Arab Emirates Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 64.United Arab Emirates Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 65.Others Continuous Glucose Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 66.Others Continuous Glucose Monitoring Devices Market, By End User, 2017-2025 ($Million)
Table 67.Medtronic: Key Strategic Developments, 2017-2017
Table 68.Dexcom: Key Strategic Developments, 2017-2017
Table 69.Abbott: Key Strategic Developments, 2017-2017
Table 70.Johnson and Johnson: Key Strategic Developments, 2017-2017
Table 71.Insulet corp.: Key Strategic Developments, 2017-2017
Table 72.Tandem diabetes: Key Strategic Developments, 2017-2017
Table 73.Echo therapeutics: Key Strategic Developments, 2017-2017
Table 74.Roche diagnostics: Key Strategic Developments, 2017-2017
Table 75.Nemaura medical Inc.: Key Strategic Developments, 2017-2017
Table 76.Senseonics: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Global Continuous Glucose Monitoring Devices Market Share, By Product, 2017 & 2025
Figure 2.Continuous Glucose Monitoring Devices Market, By Region, 2017, ($Million)
Figure 3.Continuous Glucose Monitoring Devices Market, By Product, 2017, ($Million)
Figure 4.Continuous Glucose Monitoring Devices Market, By End User, 2017, ($Million)
Figure 5.Medtronic: Net Revenues, 2017-2017 ($Million)
Figure6.Medtronic: Net Revenue Share, By Segment, 2017
Figure7.Medtronic: Net Revenue Share, By Geography, 2017
Figure 8.Dexcom: Net Revenues, 2017-2017 ($Million)
Figure 9.Dexcom: Net Revenue Share, By Segment, 2017
Figure 10.Dexcom: Net Revenue Share, By Geography, 2017
Figure 11.Abbott: Net Revenues, 2017-2017 ($Million)
Figure 12.Abbott: Net Revenue Share, By Segment, 2017
Figure 13.Abbott: Net Revenue Share, By Geography, 2017
Figure 14.ohnson and Johnson: Net Revenues, 2017-2017 ($Million)
Figure 15.Johnson and Johnson: Net Revenue Share, By Segment, 2017
Figure 16.Johnson and Johnson: Net Revenue Share, By Geography, 2017
Figure 17.Insulet corp.: Net Revenues, 2017-2017 ($Million)
Figure 18.Insulet corp.: Net Revenue Share, By Segment, 2017
Figure 19.Insulet corp.: Net Revenue Share, By Geography, 2017
Figure 20.Tandem diabetes: Net Revenues, 2017-2017 ($Million)
Figure 21.Tandem diabetes: Net Revenue Share, By Segment, 2017
Figure 22.Tandem diabetes: Net Revenue Share, By Geography, 2017
Figure 23.Echo therapeutics: Net Revenues, 2017-2017 ($Million)
Figure 24.Echo therapeutics: Net Revenue Share, By Segment, 2017
Figure 25.Echo therapeutics t Systems: Net Revenue Share, By Geography, 2017
Figure 26.Roche diagnostics: Net Revenues, 2017-2017 ($Million)
Figure 27.Roche diagnostics: Net Revenue Share, By Segment, 2017
Figure 28.Roche diagnostics: Net Revenue Share, By Geography, 2017
Figure 29.Nemaura medical Inc: Net Revenues, 2017-2017 ($Million)
Figure 30.Nemaura medical Inc: Net Revenue Share, By Segment, 2017
Figure 31.Nemaura medical Inc: Net Revenue Share, By Geography, 2017
Figure 32.Senseonics: Net Revenues, 2017-2017 ($Million)
Figure 33.Senseonics: Net Revenue Share, By Segment, 2017
Figure 34.Senseonics: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|